‘Volatility is opportunity’: why this manager loves shorting stocks

Angela Aldrich of Bayberry Capital Partners LP bet against Treasury Wine Estates at the top of the market and now she's preparing to make her next big call at this year's Sohn Hearts & Minds Conference.
Angela Aldrich of Bayberry Capital Partners in New York. Picture: Jaclyn Licht.

Joshua Peach

‘Volatility is opportunity’: why this manager loves shorting stocks

September 18, 2023
Angela Aldrich of Bayberry Capital Partners LP bet against Treasury Wine Estates at the top of the market and now she's preparing to make her next big call at this year's Sohn Hearts & Minds Conference.
Read Transcript

Four years ago, Angela Aldrich stood on a stage in New York and told the world her newly minted hedge fund Bayberry Capital Partners was shorting a winemaker listed on the other side of the world, Treasury Wine Estates.

In Australia, investors were shocked. The company, Australia’s largest wine producer, had been on a three-year tear, jumping more than 300 per cent, and was showing little sign of slowing down.

Twelve months after Aldrich stepped off that stage at the Sohn Conference in Manhattan, Treasury Wines’ shares had tumbled 45 per cent.

“Our view wasn’t that TWE was a bad company or that they were doing something nefarious. It had been such a good stock for such a long period, but it started to look like cracks were showing,” Aldrich tells The Australian Financial Review.

“It was so beloved, but you were seeing some things on the balance sheets that didn’t necessarily jibe with what the market was thinking or what had been happening over the past few years

That proved prescient after Treasury Wine Estate downgraded the earnings of its US business the following year, erasing more than $3 billion of market value. It would be the start of a difficult era for the company, worsened by harsh Chinese wine tariffs and the outbreak of COVID-19.

“At some point, everything that’s priced for perfection reaches a point where expectations get too far ahead of themselves,” Aldrich adds.

At the time of the hedge fund manager’s now infamous call on the wine producer, Bayberry Capital was barely a year old, having launched on April Fools’ Day in 2018.

Learning from the ‘tiger cub’

But Aldrich was hardly new to the fund business, having already earned the nickname “Tiger grandcub” after apprenticing under hedge fund legend and famed “Tiger cub” investor John Griffin while at Blue Ridge Capital.

It was from Griffin, whom she worked with for six years, that Aldrich developed her love of betting against a stock. She joined Blue Ridge after stints with Scout Capital and BDT Capital, and at Goldman Sachs as an investment banking analyst after obtaining her MBA from the Stanford Graduate School of Business.

“I definitely caught the short-selling virus from John,” Aldrich says. “There is no cure. I am now that crazy person who is completely attached to the short side.

“John deeply loved the short side, and he just found it incredibly interesting. And he was obviously very good at it. He believed he could make money for investors on both sides of the portfolio, and I just thought that was so interesting.”

Griffin was president at Julian Robertson’s Tiger Management before forming Blue Ridge in 1996. The firm produced annualised returns of 15.4 per cent, consistently beating the benchmark S&P 500 Index across its two decades in operation.

It closed in 2017 and Aldrich launched Bayberry Capital a year later. While the thought of starting a hedge fund in the lead-up to a once-in-a-century pandemic may produce anxiety in some, Aldrich saw it as a stress test for her new venture.

“The past few years have been an entire lifetime of economic cycles. Seeing that type of disruption first-hand when you are managing your own portfolio was a totally different experience,” she says.

“I’m grateful that we got to see all of those things, and an ability to understand what happens to our portfolio in different economic situations.”

It was in that storm of volatility that Aldrich’s mentorship under Griffin really came to the fore.

“The most important lesson that I took from him, especially given what the last four years has been, is his true ability to watch volatility unemotionally,” Aldrich says.

“We need irrational moves in our shorts to get as much juice out of every position as possible. And so it’s been really great for us in this period, no matter which way the market has been moving.”

That doesn’t mean that it’s been painless, however.

One of the hedge fund’s first substantial long positions was Nasdaq-listed Willscot Mobile Mini Holdings, which dived more than 60 per cent from peak to trough during the early months of the pandemic.

“That was a huge use of capital and this wasn’t too long after we launched the fund,” she laments.

But while everything was selling off, the fund, which typically holds around 15 longs and 40 shorts, was buying up companies on the cheap, including online car auction company Copart.

“[It] had been on my fantasy list since I was a junior analyst and had [been] sold off like it was a travel business. Despite that, they actually ended up over-earning during the COVID period”, she says.

Meanwhile, on the other side of the portfolio, Aldrich leant into the short side of the business as the market recovered.

“The subsequent rebound was so violent that we got the opportunity to play existing shorts again, shorts that we’d already covered; we got a second and a third chance.”

More recently, Bayberry made what many would consider a high-stakes bet on UK-listed Burford Capital, a legal finance outfit that had plummeted when a pending court case in Argentina worried the market.

“You’re seeing a market that is very quick to pull the sell trigger,” Aldrich says. “They had this huge outstanding piece of litigation related to about 50 per cent of their stated book value when we started looking at the stock – people thought we were insane.

“You just needed this overhang to go away and people would start buying the stock again. The cherry on top was we thought that overhang was going to go in their favour, and that finally started happening in 2023.”

After winning the case, Burford Capital’s stock recovered rapidly and is now up more than 80 per cent year to date, making it the hedge fund’s best contributor so far this year.

Rooting for the underdogs

The Burford case mimics a lot of the companies that Bayberry picks up. Aldrich, who spends much of her free time volunteering at dog rescue charities, appears to have a soft spot for underdogs in her business life as well.

“We like the weird businesses where there’s no sort of pure-play competitor peer that you can look at,” she said.

Four years after Aldrich shorted Treasury Wine Estates, the stock is still down 25 per cent from the $16-per-share price tag in 2019. Meanwhile, Aldrich’s love of shorts has only grown.

“The reason the short side is so interesting to me personally is when you have high conviction that you’re seeing the cracks in a short today, it tends to be quicker for that information to reach the broader investment community and result in a share price decline,” she says. “I think there is a bad habit going around of viewing volatility as risk. There’s risk in everything. Volatility is the opportunity.”

Angela Aldrich will join 10 other portfolio managers to speak at Sohn Hearts & Minds at the Sydney Opera House on November 17. All profits will support Australian medical research organisations.

The Australian Financial Review is a media partner for the event.

 

This article was originally posted by The Australian Financial Review here.

Licensed by Copyright Agency. You must not copy this work without permission.

Disclaimer: This material has been prepared by Australian Financial Review, published on 18 September 2023. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

Four years ago, Angela Aldrich stood on a stage in New York and told the world her newly minted hedge fund Bayberry Capital Partners was shorting a winemaker listed on the other side of the world, Treasury Wine Estates.

In Australia, investors were shocked. The company, Australia’s largest wine producer, had been on a three-year tear, jumping more than 300 per cent, and was showing little sign of slowing down.

Twelve months after Aldrich stepped off that stage at the Sohn Conference in Manhattan, Treasury Wines’ shares had tumbled 45 per cent.

“Our view wasn’t that TWE was a bad company or that they were doing something nefarious. It had been such a good stock for such a long period, but it started to look like cracks were showing,” Aldrich tells The Australian Financial Review.

“It was so beloved, but you were seeing some things on the balance sheets that didn’t necessarily jibe with what the market was thinking or what had been happening over the past few years

That proved prescient after Treasury Wine Estate downgraded the earnings of its US business the following year, erasing more than $3 billion of market value. It would be the start of a difficult era for the company, worsened by harsh Chinese wine tariffs and the outbreak of COVID-19.

“At some point, everything that’s priced for perfection reaches a point where expectations get too far ahead of themselves,” Aldrich adds.

At the time of the hedge fund manager’s now infamous call on the wine producer, Bayberry Capital was barely a year old, having launched on April Fools’ Day in 2018.

Learning from the ‘tiger cub’

But Aldrich was hardly new to the fund business, having already earned the nickname “Tiger grandcub” after apprenticing under hedge fund legend and famed “Tiger cub” investor John Griffin while at Blue Ridge Capital.

It was from Griffin, whom she worked with for six years, that Aldrich developed her love of betting against a stock. She joined Blue Ridge after stints with Scout Capital and BDT Capital, and at Goldman Sachs as an investment banking analyst after obtaining her MBA from the Stanford Graduate School of Business.

“I definitely caught the short-selling virus from John,” Aldrich says. “There is no cure. I am now that crazy person who is completely attached to the short side.

“John deeply loved the short side, and he just found it incredibly interesting. And he was obviously very good at it. He believed he could make money for investors on both sides of the portfolio, and I just thought that was so interesting.”

Griffin was president at Julian Robertson’s Tiger Management before forming Blue Ridge in 1996. The firm produced annualised returns of 15.4 per cent, consistently beating the benchmark S&P 500 Index across its two decades in operation.

It closed in 2017 and Aldrich launched Bayberry Capital a year later. While the thought of starting a hedge fund in the lead-up to a once-in-a-century pandemic may produce anxiety in some, Aldrich saw it as a stress test for her new venture.

“The past few years have been an entire lifetime of economic cycles. Seeing that type of disruption first-hand when you are managing your own portfolio was a totally different experience,” she says.

“I’m grateful that we got to see all of those things, and an ability to understand what happens to our portfolio in different economic situations.”

It was in that storm of volatility that Aldrich’s mentorship under Griffin really came to the fore.

“The most important lesson that I took from him, especially given what the last four years has been, is his true ability to watch volatility unemotionally,” Aldrich says.

“We need irrational moves in our shorts to get as much juice out of every position as possible. And so it’s been really great for us in this period, no matter which way the market has been moving.”

That doesn’t mean that it’s been painless, however.

One of the hedge fund’s first substantial long positions was Nasdaq-listed Willscot Mobile Mini Holdings, which dived more than 60 per cent from peak to trough during the early months of the pandemic.

“That was a huge use of capital and this wasn’t too long after we launched the fund,” she laments.

But while everything was selling off, the fund, which typically holds around 15 longs and 40 shorts, was buying up companies on the cheap, including online car auction company Copart.

“[It] had been on my fantasy list since I was a junior analyst and had [been] sold off like it was a travel business. Despite that, they actually ended up over-earning during the COVID period”, she says.

Meanwhile, on the other side of the portfolio, Aldrich leant into the short side of the business as the market recovered.

“The subsequent rebound was so violent that we got the opportunity to play existing shorts again, shorts that we’d already covered; we got a second and a third chance.”

More recently, Bayberry made what many would consider a high-stakes bet on UK-listed Burford Capital, a legal finance outfit that had plummeted when a pending court case in Argentina worried the market.

“You’re seeing a market that is very quick to pull the sell trigger,” Aldrich says. “They had this huge outstanding piece of litigation related to about 50 per cent of their stated book value when we started looking at the stock – people thought we were insane.

“You just needed this overhang to go away and people would start buying the stock again. The cherry on top was we thought that overhang was going to go in their favour, and that finally started happening in 2023.”

After winning the case, Burford Capital’s stock recovered rapidly and is now up more than 80 per cent year to date, making it the hedge fund’s best contributor so far this year.

Rooting for the underdogs

The Burford case mimics a lot of the companies that Bayberry picks up. Aldrich, who spends much of her free time volunteering at dog rescue charities, appears to have a soft spot for underdogs in her business life as well.

“We like the weird businesses where there’s no sort of pure-play competitor peer that you can look at,” she said.

Four years after Aldrich shorted Treasury Wine Estates, the stock is still down 25 per cent from the $16-per-share price tag in 2019. Meanwhile, Aldrich’s love of shorts has only grown.

“The reason the short side is so interesting to me personally is when you have high conviction that you’re seeing the cracks in a short today, it tends to be quicker for that information to reach the broader investment community and result in a share price decline,” she says. “I think there is a bad habit going around of viewing volatility as risk. There’s risk in everything. Volatility is the opportunity.”

Angela Aldrich will join 10 other portfolio managers to speak at Sohn Hearts & Minds at the Sydney Opera House on November 17. All profits will support Australian medical research organisations.

The Australian Financial Review is a media partner for the event.

 

This article was originally posted by The Australian Financial Review here.

Licensed by Copyright Agency. You must not copy this work without permission.

Disclaimer: This material has been prepared by Australian Financial Review, published on 18 September 2023. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

Disclaimer: This material has been prepared by Australian Financial Review, published on Sep 18, 2023. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

facebook
linkedin
All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Eminence Capital founder Ricky Sandler in Sydney. Picture: John Feder‍Eminence Capital founder Ricky Sandler in Sydney. Picture: John Feder‍Eminence Capital founder Ricky Sandler in Sydney. Picture: John Feder‍Eminence Capital founder Ricky Sandler in Sydney. Picture: John Feder‍
November 6, 2024

Why this New York hedge fund manager sees opportunity in European stocks

Influential New York-hedge fund manager Ricky Sandler will turn to Europe for his next stock pick.

Read More
Vihari Ross of Antipodes. Picture: Louie DouvisVihari Ross of Antipodes. Picture: Louie DouvisVihari Ross of Antipodes. Picture: Louie DouvisVihari Ross of Antipodes. Picture: Louie Douvis
November 5, 2024

Antipodes’ Ross says short-term wealth hinges on US election

The portfolio manager says defensive stocks pose a bigger risk than the magnificent seven for investors that are overexposed to the American sharemarket.

Read More
Antipodes Partners portfolio manager Vihari Ross: ‘We ask where the overvaluation is and where the opportunity is.’ Picture: John FederAntipodes Partners portfolio manager Vihari Ross: ‘We ask where the overvaluation is and where the opportunity is.’ Picture: John FederAntipodes Partners portfolio manager Vihari Ross: ‘We ask where the overvaluation is and where the opportunity is.’ Picture: John FederAntipodes Partners portfolio manager Vihari Ross: ‘We ask where the overvaluation is and where the opportunity is.’ Picture: John Feder
November 5, 2024

Concentration risk key for investors: Antipodes Partners’ Vihari Ross

The concentration risk in global stock indexes that has built up during the strong rise over the past year must now be a key consideration for global investors, according to Vihari Ross.

Read More
JO Hambro Asset Management senior portfolio manager Samir Mehta.JO Hambro Asset Management senior portfolio manager Samir Mehta.JO Hambro Asset Management senior portfolio manager Samir Mehta.JO Hambro Asset Management senior portfolio manager Samir Mehta.
November 5, 2024

The fundie betting big on China – with help from AI

Mr Mehta is sticking to his well-worn strategy: he’s hunting for companies across Asia that aren’t battling intense competition and have management teams focused on costs, cash generation and high payouts to shareholders.

Read More
Beeneet Kothari is ready to shock the Sohn Hearts & Minds event.Beeneet Kothari is ready to shock the Sohn Hearts & Minds event.Beeneet Kothari is ready to shock the Sohn Hearts & Minds event.Beeneet Kothari is ready to shock the Sohn Hearts & Minds event.
October 29, 2024

Why this fundie wants you to ‘wince’ at his stock picks

When fund managers come to pitch their favourite stock at the annual Sohn Hearts & Minds conference, there are two ways they can go: they can play it safe, or they can take a risk and shock the room.

Read More
October 27, 2024

IFM Investors’ Rikki Bannan backs small cap investments to rebound after mixed performance

IFM Investors executive director Rikki Bannan believes this year could be a good one to invest in some select small cap stocks.

Read More
October 22, 2024

Meet the 2024 Conference Managers

Following a global search, the Conference Fund Manager Selection Committee is pleased to share eleven new managers for 2024.

Read More
October 21, 2024

Chris Kourtis is on a winning streak. Here’s his next ASX pick

Chris Kourtis of Ellerston Capital thinks he’s found another winner and thinks it’s the last chance to have a bite at the cherry before the strategy plays out.

Read More
Ellerston Capital portfolio manager Chris Kourtis. Picture: Britta CampionEllerston Capital portfolio manager Chris Kourtis. Picture: Britta CampionEllerston Capital portfolio manager Chris Kourtis. Picture: Britta CampionEllerston Capital portfolio manager Chris Kourtis. Picture: Britta Campion
October 21, 2024

Why Ellerston Capital’s Chris Kourtis plans to back a ‘hated’ stock

Chris Kourtis of Ellerston Capital plans to tip one of the “most hated” stocks in Australia when he presents at the 2024 Sohn Hearts & Minds Conference.

Read More
 ‘We’re riding a wave which started (with) the first silicon chips,’ Alex Pollak says. Picture: Britta Campion ‘We’re riding a wave which started (with) the first silicon chips,’ Alex Pollak says. Picture: Britta Campion ‘We’re riding a wave which started (with) the first silicon chips,’ Alex Pollak says. Picture: Britta Campion ‘We’re riding a wave which started (with) the first silicon chips,’ Alex Pollak says. Picture: Britta Campion
October 14, 2024

Alex Pollak champions rewards of disruptive investment

Alex Pollak’s funds management company Loftus Peak rode the Nvidia wave and he is now looking at more opportunities in disruptive industry stocks.

Read More
October 8, 2024

Sumit Gautam - Why AI won't deliver in 2025 | Scalar Gauge

Sumit Gautam is the Founder of Scalar Gauge and speaks with Equity Mates ahead of his appearance at the Sohn Hearts & Minds conference.

Read More
September 30, 2024

Missed out on Nvidia and Ozempic? This fundie says it’s never too late

Northcape Capital’s Fleur Wright is still kicking herself for not owning market darlings Nvidia and Novo Nordisk, the maker of the weight loss wonder drug Ozempic, before shares of those companies rocketed in 2023.

Read More
September 23, 2024

Scalar Gauge Fund founder Sumit Gautam cautious about over-hyped AI

Tech investor Sumit Gautam carefully avoids the word bubble when describing the investor frenzy surrounding the rise of artificial intelligence, but warns there are dangers of getting caught up in the hype.

Read More
September 9, 2024

The Wellcome Trust’s Nick Moakes made a 100-year bet. It’s paying off

Chief Investment Officer, Nick Moakes raised almost $3 billion at ultra-low rates. Sometimes the long view can be the most profitable.

Read More
Wellcome Trust chief investment officer Nicholas Moakes. Picture: Steven PocockWellcome Trust chief investment officer Nicholas Moakes. Picture: Steven PocockWellcome Trust chief investment officer Nicholas Moakes. Picture: Steven PocockWellcome Trust chief investment officer Nicholas Moakes. Picture: Steven Pocock
September 5, 2024

Honesty the only policy that matters, says Wellcome Trust’s Nicholas Moakes

The chief investment officer of the London-based $71bn Wellcome Trust, Nick Moakes, has a simple rule for the trust’s investment team: “Never invest with anyone who is or has been or should have been in prison.”

Read More
December 10, 2024

Professor Jane Butler: Sparking Hope for Spinal Cord Injuries

In this episode of the Hearts & Minds Podcast, we sit down with Professor Jane Butler to discuss her groundbreaking research into spinal cord injuries.

Read More
impact-podcasts
September 24, 2024

Asian Market Potential with Tom Naughton of Prusik

CIO Charlie Lanchester sits down with Tom Naughton, CIO of Prusik Investment Mgmt. Tom shares his investment philosophy, the opportunities and challenges in Asian markets, and how his 2023 conference stock pick, Swire Pacific (0019.HK), delivered an impressive 30% return.

Read More
investing
September 4, 2024

Building Hearts and Minds with Co-Founders Matthew Grounds and Guy Fowler

In this episode, co-founders Matthew Grounds AM and Guy Fowler OAM discuss their journey in building Hearts & Minds and its philanthropic model that has donated over $70 million to medical research.

Read More
investing
June 25, 2024

Navigating the Resource Sector with Jeremy Bond of Terra Capital

In this episode, we chat with Jeremy Bond, Founder of Terra Capital and HM1 Conference Fund Manager. Tune in for insights into the world of resource investments and the exciting opportunities that lie ahead.

Read More
investing
June 11, 2024

Prof. Nadia Badawi on Cerebral Palsy Breakthroughs and Neonatal Care

Dive deep into the groundbreaking work of Professor Nadia Badawi, an internationally recognised neonatologist and expert in Cerebral Palsy.

Read More
impact-podcasts
May 28, 2024

Investment Insights: Rikki Bannan on Top Picks and Trends

Join us for an engaging episode featuring Rikki Bannan, Portfolio Manager of IFM Investors and HM1 Conference Fund Manager. This episode explores Rikki's career journey, investment strategies, and her 2023 conference stock pick, Telix Pharmaceuticals (ASX.TLX).

Read More
investing
December 6, 2023

Peter Cooper talks building and instilling a culture of humility and excellence

In this episode, our guest is the renowned investor, Peter Cooper, founder and Chief Investment Officer of Cooper Investors (Core Fund Manager). A founding supporter of Hearts and Minds, Peter is a staunch advocate of our model and its philanthropic purpose, actively engaging in every facet of Hearts and Minds.

Read More
investing
November 28, 2023

Jun Bei Liu on her high conviction investment strategy

In this episode, HM1 Chief Investment Officer Charlie Lanchester is joined by Jun Bei Liu. Jun Bei is the Portfolio Manager of Tribeca’s Alpha Plus Fund and since taking over managing the Fund, she has quadrupled AUM.

Read More
investing
November 21, 2023

The world of rare genetic disease research

In this episode, we speak to Associate Professor Gina Ravenscroft. Gina is an Associate Professor in Neurogenetics at the Harry Perkins Institute of Medical Research in Perth. Her research interests are in rare genetic diseases, with a particular focus on neurogenetic diseases in babies and children.

Read More
impact-podcasts
November 14, 2023

Learn what makes a high conviction investment and how to avoid short-term noise

In this episode, our Core Fund Manager Magellan shares how they select top stocks for the HM1 portfolio.

Read More
investing
November 7, 2023

Delve into the world of kids critical care and trauma research

In thie episode, we are joined by Dr. Marino Festa, or Rino for short. He is the Medical Director of NSW Kids ECMO Referral Service and a senior specialist in Paediatric Intensive Care at Children’s Hospital at Westmead.

Read More
impact-podcasts
October 31, 2023

Where Regal's Phil King is searching for opportunities

HM1's CIO, Charlie Lanchester, talks to Phil King of Regal Funds about his passion for stocks, his ongoing search for opportunities, and some of the sectors he’s excited by right now. Phil King of Regal Funds, has been a tremendous supporter of Hearts & Minds since the beginning.

Read More
investing
October 24, 2023

Preventing recurrent miscarriages and birth defects

In this episode, CEO Paul Rayson is joined by renowned biomedical researcher Professor Sally Dunwoodie. Prof. Dunwoodie's groundbreaking work has revolutionised clinical practices and enabled genetic diagnostic tests worldwide. In 2017, her team achieved a double breakthrough with the potential to prevent recurrent miscarriages and various birth defects.

Read More
impact-podcasts
October 17, 2023

Nick Griffin on how he finds global winners

In this episode, CIO Charlie Lanchester chats with Nick Griffin, the founding partner and CIO of Munro Partners, one of HM1's Core Fund Managers. They go over his career to date, reflect on the lessons he’s learned, and trace the decisions that led to him starting Munro.

Read More
investing
October 10, 2023

How A/Prof Matt Call is teaching our body to kill cancer

In this episode, CEO Paul Rayson is joined by WEHI’s Associate Professor Matt Call to talk about his incredible research. Matt’s team teaches and trains the body's own immune cells to target and kill cancer cells.

Read More
impact-podcasts

No results found.

Please try a different search keyword or filter.